View in EDS

Rethinking informed consent in phage therapy: why location and approach matter.

Saved in:
Bibliographic Details
Title: Rethinking informed consent in phage therapy: why location and approach matter.
Authors: Nir-Paz R; ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel; Israeli Phage Therapy Center of Hadassah Medical Center and the Hebrew University, Jerusalem, Israel. Electronic address: NIRPAZ@hadassah.org.il., Pirnay JP; ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, Belgium., Ferry T; ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Infectious Diseases, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France; Centre interrégional de référence pour la prise en charge des infections ostéoarticulaires complexes, CRIOAc Lyon, Hospices Civils de Lyon, Lyon, France; Claude Bernard Lyon 1 University, Lyon, France., Drulis-Kawa Z; ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Department of Pathogen Biology and Immunology, University of Wroclaw, Wroclaw, Poland., Classen AY; ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Department I for Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany., Scobie AI; ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Department of Infection, Royal Free London NHS Foundation Trust, UK; Bone Infection Unit, Royal National Orthopaedic Hospital NHS Trust, UK; Division of Infection and Immunity, University College London, UK., Lester R; ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Department of Infection, Royal Free London NHS Foundation Trust, UK; Division of Infection and Immunity, University College London, UK., Katvan E; Law School and Health Management Program, Peres Academic Center, Rehovot, Israel., Hafkemeyer S; Mukoviszidose Institut GmbH, subsidiary of the German Cystic Fibrosis association Mukoviszidose e. V., Bonn, Germany., McCallin S; ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland; Spinal Cord Injury Center, Balgrist University Hospital, University of Zürich, Zürich, CH, Switzerland., Suh GA; ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
Source: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2026 Aug; Vol. 32 (8), pp. 1211-1215. Date of Electronic Publication: 2026 Apr 10.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9516420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-0691 (Electronic) Linking ISSN: 1198743X NLM ISO Abbreviation: Clin Microbiol Infect Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41967803
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Rethinking informed consent in phage therapy: why location and approach matter.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nir-Paz+R%22">Nir-Paz R</searchLink>; ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel; Israeli Phage Therapy Center of Hadassah Medical Center and the Hebrew University, Jerusalem, Israel. Electronic address: NIRPAZ@hadassah.org.il.<br /><searchLink fieldCode="AU" term="%22Pirnay+JP%22">Pirnay JP</searchLink>; ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Ferry+T%22">Ferry T</searchLink>; ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Infectious Diseases, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France; Centre interrégional de référence pour la prise en charge des infections ostéoarticulaires complexes, CRIOAc Lyon, Hospices Civils de Lyon, Lyon, France; Claude Bernard Lyon 1 University, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Drulis-Kawa+Z%22">Drulis-Kawa Z</searchLink>; ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Department of Pathogen Biology and Immunology, University of Wroclaw, Wroclaw, Poland.<br /><searchLink fieldCode="AU" term="%22Classen+AY%22">Classen AY</searchLink>; ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Department I for Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Scobie+AI%22">Scobie AI</searchLink>; ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Department of Infection, Royal Free London NHS Foundation Trust, UK; Bone Infection Unit, Royal National Orthopaedic Hospital NHS Trust, UK; Division of Infection and Immunity, University College London, UK.<br /><searchLink fieldCode="AU" term="%22Lester+R%22">Lester R</searchLink>; ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Department of Infection, Royal Free London NHS Foundation Trust, UK; Division of Infection and Immunity, University College London, UK.<br /><searchLink fieldCode="AU" term="%22Katvan+E%22">Katvan E</searchLink>; Law School and Health Management Program, Peres Academic Center, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Hafkemeyer+S%22">Hafkemeyer S</searchLink>; Mukoviszidose Institut GmbH, subsidiary of the German Cystic Fibrosis association Mukoviszidose e. V., Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22McCallin+S%22">McCallin S</searchLink>; ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland; Spinal Cord Injury Center, Balgrist University Hospital, University of Zürich, Zürich, CH, Switzerland.<br /><searchLink fieldCode="AU" term="%22Suh+GA%22">Suh GA</searchLink>; ESGNTA - ESCMID Study Group for Non-Traditional Antibacterials, Basel, Switzerland; Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229516420%22">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</searchLink> [Clin Microbiol Infect] 2026 Aug; Vol. 32 (8), pp. 1211-1215. <i>Date of Electronic Publication: </i>2026 Apr 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9516420 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1469-0691 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221198743X%22">1198743X </searchLink><i>NLM ISO Abbreviation: </i>Clin Microbiol Infect <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41967803
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.cmi.2026.04.007
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1211
    Titles:
      – TitleFull: Rethinking informed consent in phage therapy: why location and approach matter.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nir-Paz R
      – PersonEntity:
          Name:
            NameFull: Pirnay JP
      – PersonEntity:
          Name:
            NameFull: Ferry T
      – PersonEntity:
          Name:
            NameFull: Drulis-Kawa Z
      – PersonEntity:
          Name:
            NameFull: Classen AY
      – PersonEntity:
          Name:
            NameFull: Scobie AI
      – PersonEntity:
          Name:
            NameFull: Lester R
      – PersonEntity:
          Name:
            NameFull: Katvan E
      – PersonEntity:
          Name:
            NameFull: Hafkemeyer S
      – PersonEntity:
          Name:
            NameFull: McCallin S
      – PersonEntity:
          Name:
            NameFull: Suh GA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2026 Aug
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1469-0691
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
              Type: main
ResultId 1